Furthermore, in vitro studies using purified human MLH1 and PMS2 proteins found that MMR activity was significantly decreased with MLH1-E34A [42], and mutations in the ATPase domain of MLH1 are associated with cancer risk [43–45]. Here, MLH1 is linked to cancer.